دورية أكاديمية

Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters

التفاصيل البيبلوغرافية
العنوان: Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
المؤلفون: Nazari, Somayeh, Mosaffa, Fatemeh, Poustforoosh, Alireza, Mortazavi, Motahareh, Saso, Luciano, Firuzi, Omidreza, Moosavi, Fatemeh
المصدر: In Toxicology and Applied Pharmacology March 2024 484
قاعدة البيانات: ScienceDirect
الوصف
تدمد:0041008X
DOI:10.1016/j.taap.2024.116866